Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of GLP-1 Receptor Agonists on Breast Reconstruction Outcomes: A Large-Database Retrospective Study.

Journal of clinical medicine·2026
Same author

Venous thromboembolism risk in sarcoma patients receiving combined immune checkpoint inhibitors and VEGF pathway inhibitors: a real-world cohort study.

Translational cancer research·2026
Same author

The Impact of Breast Reconstruction on Smoking Cessation Among Patients With Breast Cancer.

Journal of surgical oncology·2026
Same author

Establishing a Predictive Perfusion Threshold Using SPY-PHI QP in Staged Breast Reconstruction: A Prospective Evaluation With Nitroglycerin Adjustment.

Aesthetic surgery journal·2026
Same author

"Age is just a number": Deep inferior epigastric perforator flaps are safe across different age groups.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2026
Same author

Fat survival following autologous fat transfer to the native breast: A systematic review and meta-analysis.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2026

Related Experiment Video

Updated: Jun 26, 2025

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

6.9K

Enormous myxoid/round cell liposarcoma: A case report.

Joshua R Finlay1, Gayathri Vijayakumar1, Ankica Braun2

  • 1Department of Orthopedic Surgery, Division of Orthopedic Oncology, Rush University Medical Center, Chicago, IL, USA.

Rare Tumors
|May 20, 2024
PubMed
Summary

This case report details the largest myxoid/round cell liposarcoma (MRCLPS) treated at our institution. Management of this large soft tissue sarcoma required a multidisciplinary approach due to significant complications.

Area of Science:

  • Oncology
  • Surgical Pathology
  • Sarcoma Research

Background:

  • Myxoid/round cell liposarcomas (MRCLPS) are rare malignant soft tissue tumors.
Keywords:
Myxoid liposarcomalarge sarcomamultidisciplinarymyxoid/round cell liposarcomassoft tissue sarcoma

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.3K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

1.9K

Related Experiment Videos

Last Updated: Jun 26, 2025

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

6.9K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.3K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

1.9K
  • Large MRCLPS present unique clinical and surgical challenges.
  • Institutional experience with exceptionally large MRCLPS is limited.